Patients: Patients undergoing BMT were seen by an ophthalmologist for clinical care and enrolled in a long-term follow-up study, during which they were seen 6 and 12 months after the transplantation and annually thereafter. (1) allogeneic, in which an HLA-matched do¬ nor, such as a sibling, is used; (2) syngeneic, in which the donor is a monozygotic twin; or (3) autologous, in which case the patient's own stored and chemotherapeutically purged marrow is trans¬ planted. Complications ofBMT include (1) hemorrhage due to aplasia during the early posttransplantation period; (2) (1) hemorrhagic1011; (2) microvascular retinopathy1720; (3) optic disc edema19·21; (4) (Figure 1, top) (Figure 3, top) . A diagnostic vitrectomy was per¬ formed. Cuttures for bacteria, fungi, and viruses were negative. Cytologie examination of the specimen showed atypical lymphocytes and nuclear atypia in large lymphocytes diagnostic of intraocular lymphoma (Figure 3, center) . Because 
